MHRA joins Consortium of Regulators - without EU
Recommendation
20/21 October 2026
Understanding the Importance of GMP
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium.
The ACSS consortium was formed in 2007 and comprised the national regulatory authorities of Australia, Canada, Singapore and Switzerland. Now, after MHRA has joined, the group's name was changed to 'Access'. The MHRA will commence work-sharing applications with Access partners from 1 January 2021. The members aim to promote greater regulatory collaboration and alignment of regulatory requirements. In this context he Access Consortium explores opportunities for information and work-sharing in areas including:
- generic medicines registration
- assessment reports for new prescription medicines
- information sharing and investigations into post-market medicine safety
- alignment of IT systems for information sharing
- development of technical guidelines.
Related GMP News
14.10.2026EU Pharma Package: Council Adopts New Rules
14.10.2026ICH Publishes New Training Material for Quality Guidelines
14.10.2026WHO issues Draft Guidance on Quality Risk Management
26.08.2026GMP and "Planned Deviations" - a Contradiction?
19.08.2026Why Root Cause Analysis is the Key to efficient CAPA
19.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan